Search Results

There are 24677 results for: content related to: Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice

  1. You have free access to this content
    A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth

    International Journal of Cancer

    Volume 129, Issue 8, 15 October 2011, Pages: 2013–2024, Rob C. Roovers, Maria J.W.D. Vosjan, Toon Laeremans, Rachid el Khoulati, Renée C.G. de Bruin, Kathryn M. Ferguson, Arie J. Verkleij, Guus A.M.S. van Dongen and Paul M.P. van Bergen en Henegouwen

    Version of Record online : 8 AUG 2011, DOI: 10.1002/ijc.26145

  2. 99mTc-anti-epidermal growth factor receptor nanobody for tumor imaging

    Chemical Biology & Drug Design

    Majid Piramoon, Seyed Jalal Hosseinimehr, Kobra Omidfar, Zohreh Noaparast and Seyed Mohammad Abedi

    Version of Record online : 5 NOV 2016, DOI: 10.1111/cbdd.12871

  3. Affinity capillary electrophoresis to evaluate the complex formation between poliovirus and nanobodies

    Journal of Separation Science

    Volume 37, Issue 24, December 2014, Pages: 3729–3737, Hadewych Halewyck, Lise Schotte, Iuliana Oita, Bert Thys, Ann Van Eeckhaut, Yvan Vander Heyden and Bart Rombaut

    Version of Record online : 12 NOV 2014, DOI: 10.1002/jssc.201400406

  4. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer

    Contrast Media & Molecular Imaging

    Volume 9, Issue 3, May/June 2014, Pages: 211–220, Mehdi Evazalipour, Matthias D'Huyvetter, Bahram Soltani Tehrani, Mohsen Abolhassani, Kobra Omidfar, Shahriyar Abdoli, Roghaye Arezumand, Hamid Morovvati, Tony Lahoutte, Serge Muyldermans and Nick Devoogdt

    Version of Record online : 6 MAR 2014, DOI: 10.1002/cmmi.1558

  5. You have free access to this content
    Structural and thermodynamic analysis of the GFP:GFP-nanobody complex

    Protein Science

    Volume 19, Issue 12, December 2010, Pages: 2389–2401, Marta H. Kubala, Oleksiy Kovtun, Kirill Alexandrov and Brett M. Collins

    Version of Record online : 18 NOV 2010, DOI: 10.1002/pro.519

  6. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators

    Contrast Media & Molecular Imaging

    Volume 7, Issue 2, March/April 2012, Pages: 254–264, Matthias D'Huyvetter, An Aerts, Catarina Xavier, Ilse Vaneycken, Nick Devoogdt, Marlies Gijs, Nathalie Impens, Sarah Baatout, Bernard Ponsard, Serge Muyldermans, Vicky Caveliers and Tony Lahoutte

    Version of Record online : 20 MAR 2012, DOI: 10.1002/cmmi.491

  7. Anti-c-MET Nanobody® – a new potential drug in multiple myeloma treatment

    European Journal of Haematology

    Volume 91, Issue 5, November 2013, Pages: 399–410, Tobias Schmidt Slørdahl, Tinneke Denayer, Siv Helen Moen, Therese Standal, Magne Børset, Cedric Ververken and Torstein Baade Rø

    Version of Record online : 16 SEP 2013, DOI: 10.1111/ejh.12185

  8. You have free access to this content
    TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 11, November 2011, Pages: 2268–2277, M. L. V. HENDRICKX, A. DE WINTER, K. BUELENS, G. COMPERNOLLE, G. HASSANZADEH-GHASSABEH, S. MUYLDERMANS, A. GILS and P. J. DECLERCK

    Version of Record online : 1 NOV 2011, DOI: 10.1111/j.1538-7836.2011.04495.x

  9. Mapping cytoskeletal protein function in cells by means of nanobodies


    Volume 70, Issue 10, October 2013, Pages: 604–622, Isabel Van Audenhove, Katrien Van Impe, David Ruano-Gallego, Sarah De Clercq, Kevin De Muynck, Berlinda Vanloo, Hanne Verstraete, Luis Á. Fernández and Jan Gettemans

    Version of Record online : 10 JUL 2013, DOI: 10.1002/cm.21122

  10. You have free access to this content
    Identification of a novel, nanobody-induced, mechanism of TAFI inactivation and its in vivo application

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 2, February 2014, Pages: 229–236, M. L. V. Hendrickx, M. Zatloukalova, G. Hassanzadeh-Ghassabeh, S. Muyldermans, A. Gils and P. J. Declerck

    Version of Record online : 7 FEB 2014, DOI: 10.1111/jth.12473

  11. Nanobody Platform for Determination of Protein Structure, Application of

    Standard Article

    Encyclopedia of Analytical Chemistry

    Bjoern Traenkle, Philipp D. Kaiser and Ulrich Rothbauer

    Published Online : 15 JUN 2016, DOI: 10.1002/9780470027318.a9548

  12. You have free access to this content
    Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 6, June 2010, Pages: 1302–1312, K. BUELENS, G. HASSANZADEH-GHASSABEH, S. MUYLDERMANS, A. GILS and P. J. DECLERCK

    Version of Record online : 17 FEB 2010, DOI: 10.1111/j.1538-7836.2010.03816.x

  13. You have free access to this content
    The art of blocking ADP-ribosyltransferases (ARTs): Nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs

    The FEBS Journal

    Volume 280, Issue 15, August 2013, Pages: 3543–3550, Stephan Menzel, Björn Rissiek, Friedrich Haag, Fernando A. Goldbaum and Friedrich Koch-Nolte

    Version of Record online : 14 JUN 2013, DOI: 10.1111/febs.12313

  14. Resurfaced cell-penetrating nanobodies: A potentially general scaffold for intracellularly targeted protein discovery

    Protein Science

    Volume 25, Issue 6, June 2016, Pages: 1129–1137, Virginia J. Bruce, Monica Lopez-Islas and Brian R. McNaughton

    Version of Record online : 4 APR 2016, DOI: 10.1002/pro.2926

  15. You have free access to this content
    Increased zymogen activity of thrombin-activatable fibrinolysis inhibitor prolongs clot lysis

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 6, June 2012, Pages: 1091–1099, N. MISHRA, K. BUELENS, S. THEYSKENS, G. COMPERNOLLE, A. GILS and P. J. DECLERCK

    Version of Record online : 31 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04738.x

  16. You have free access to this content
    Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier

    British Journal of Pharmacology

    Volume 165, Issue 7, April 2012, Pages: 2341–2353, G Caljon, V Caveliers, T Lahoutte, B Stijlemans, GH Ghassabeh, J Van Den Abbeele, I Smolders, P De Baetselier, Y Michotte, S Muyldermans, S Magez and R Clinckers

    Version of Record online : 9 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01723.x

  17. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris

    Biotechnology and Applied Biochemistry

    Volume 63, Issue 2, March/April 2016, Pages: 200–205, Roghayyeh Baghban, Seyed Latif Mousavi Gargari, Masoumeh Rajabibazl, Shahram Nazarian and Hamid Bakherad

    Version of Record online : 18 APR 2016, DOI: 10.1002/bab.1226

  18. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection

    Contrast Media & Molecular Imaging

    Volume 10, Issue 5, September/October 2015, Pages: 367–378, Peter Bannas, Alexander Lenz, Valentin Kunick, Lennart Well, William Fumey, Björn Rissiek, Friedrich Haag, Joanna Schmid, Kerstin Schütze, Anna Eichhoff, Martin Trepel, Gerhard Adam, Harald Ittrich and Friedrich Koch-Nolte

    Version of Record online : 27 APR 2015, DOI: 10.1002/cmmi.1637

  19. Imaging EGFR and HER2 by PET and SPECT: A Review

    Medicinal Research Reviews

    Volume 34, Issue 3, May 2014, Pages: 596–643, Emily B. Corcoran and Robert N. Hanson

    Version of Record online : 29 AUG 2013, DOI: 10.1002/med.21299

  20. Minimalist Antibodies and Mimetics: An Update and Recent Applications


    Volume 17, Issue 20, October 17, 2016, Pages: 1892–1899, Virginia J. Bruce, Angeline N. Ta and Prof. Brian R. McNaughton

    Version of Record online : 4 SEP 2016, DOI: 10.1002/cbic.201600303